Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway
Accumulating evidence indicates that the regimen to increase adiponectin will provide a novel therapeutic strategy for inflammation and cardiovascular disorders. Here, we tested the effect of troglitazone (TG) and its newly synthesized derivative, 5-[4-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl-met...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/726068 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832566691993747456 |
---|---|
author | Jaw-Shiun Tsai Lee-Ming Chuang Ching-Shih Chen Chan-Jung Liang Yuh-Lien Chen Ching-Yu Chen |
author_facet | Jaw-Shiun Tsai Lee-Ming Chuang Ching-Shih Chen Chan-Jung Liang Yuh-Lien Chen Ching-Yu Chen |
author_sort | Jaw-Shiun Tsai |
collection | DOAJ |
description | Accumulating evidence indicates that the regimen to increase adiponectin will provide a novel therapeutic strategy for inflammation and cardiovascular disorders. Here, we tested the effect of troglitazone (TG) and its newly synthesized derivative, 5-[4-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl-methoxy)-benzylidene]-2,4-thiazolidinedione (Δ2troglitazone, (Δ2TG)), on the adiponectin expression in monocytes/macrophages and the relative mechanisms. The expression of adiponectin was located in macrophages of atherosclerotic lesions from patients and cholesterol-fed rabbits. TG and Δ2TG enhanced adiponectin mRNA and protein expression in THP-1 cells by quantitative real-time PCR, Western blot, and immunocytochemistry. TG induced adiponectin mRNA expression through a PPARγ-dependent pathway whereas Δ2TG enhanced adiponectin mRNA expression through a PPARγ-independent pathway in THP-1 cells. Both TG and Δ2TG enhanced adiponectin mRNA expression through AMP-activated protein kinase (AMPK) activation. TG and Δ2TG decreased the adhesion of THP-1 cells to TNF-α-treated HUVECs and the inhibitory effect was abolished by specific antiadiponectin antibodies. TG- and Δ2TG-induced suppression on monocyte adhesion were inhibited by a selective AMPK inhibitor compound C. Our data suggest that the inhibitory effect of TG and Δ2TG on monocyte adhesion might be at least in part through de novo adiponectin expression and activation of an AMPK-dependent pathway, which might play an important role in anti-inflammation and antiatherosclerosis. |
format | Article |
id | doaj-art-9393de5b09534093b6b0b396bf5318e7 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-9393de5b09534093b6b0b396bf5318e72025-02-03T01:03:32ZengWileyMediators of Inflammation0962-93511466-18612014-01-01201410.1155/2014/726068726068Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase PathwayJaw-Shiun Tsai0Lee-Ming Chuang1Ching-Shih Chen2Chan-Jung Liang3Yuh-Lien Chen4Ching-Yu Chen5Department of Family Medicine, College of Medicine, National Taiwan University, Taipei 10051, TaiwanDepartment of Internal Medicine, College of Medicine, National Taiwan University, Taipei 10051, TaiwanDivision of Medicinal Chemistry, College of Pharmacy and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USADepartment of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei 10051, TaiwanDepartment of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei 10051, TaiwanDepartment of Family Medicine, College of Medicine, National Taiwan University, Taipei 10051, TaiwanAccumulating evidence indicates that the regimen to increase adiponectin will provide a novel therapeutic strategy for inflammation and cardiovascular disorders. Here, we tested the effect of troglitazone (TG) and its newly synthesized derivative, 5-[4-(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl-methoxy)-benzylidene]-2,4-thiazolidinedione (Δ2troglitazone, (Δ2TG)), on the adiponectin expression in monocytes/macrophages and the relative mechanisms. The expression of adiponectin was located in macrophages of atherosclerotic lesions from patients and cholesterol-fed rabbits. TG and Δ2TG enhanced adiponectin mRNA and protein expression in THP-1 cells by quantitative real-time PCR, Western blot, and immunocytochemistry. TG induced adiponectin mRNA expression through a PPARγ-dependent pathway whereas Δ2TG enhanced adiponectin mRNA expression through a PPARγ-independent pathway in THP-1 cells. Both TG and Δ2TG enhanced adiponectin mRNA expression through AMP-activated protein kinase (AMPK) activation. TG and Δ2TG decreased the adhesion of THP-1 cells to TNF-α-treated HUVECs and the inhibitory effect was abolished by specific antiadiponectin antibodies. TG- and Δ2TG-induced suppression on monocyte adhesion were inhibited by a selective AMPK inhibitor compound C. Our data suggest that the inhibitory effect of TG and Δ2TG on monocyte adhesion might be at least in part through de novo adiponectin expression and activation of an AMPK-dependent pathway, which might play an important role in anti-inflammation and antiatherosclerosis.http://dx.doi.org/10.1155/2014/726068 |
spellingShingle | Jaw-Shiun Tsai Lee-Ming Chuang Ching-Shih Chen Chan-Jung Liang Yuh-Lien Chen Ching-Yu Chen Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway Mediators of Inflammation |
title | Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway |
title_full | Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway |
title_fullStr | Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway |
title_full_unstemmed | Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway |
title_short | Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway |
title_sort | troglitazone and δ2troglitazone enhance adiponectin expression in monocytes macrophages through the amp activated protein kinase pathway |
url | http://dx.doi.org/10.1155/2014/726068 |
work_keys_str_mv | AT jawshiuntsai troglitazoneandd2troglitazoneenhanceadiponectinexpressioninmonocytesmacrophagesthroughtheampactivatedproteinkinasepathway AT leemingchuang troglitazoneandd2troglitazoneenhanceadiponectinexpressioninmonocytesmacrophagesthroughtheampactivatedproteinkinasepathway AT chingshihchen troglitazoneandd2troglitazoneenhanceadiponectinexpressioninmonocytesmacrophagesthroughtheampactivatedproteinkinasepathway AT chanjungliang troglitazoneandd2troglitazoneenhanceadiponectinexpressioninmonocytesmacrophagesthroughtheampactivatedproteinkinasepathway AT yuhlienchen troglitazoneandd2troglitazoneenhanceadiponectinexpressioninmonocytesmacrophagesthroughtheampactivatedproteinkinasepathway AT chingyuchen troglitazoneandd2troglitazoneenhanceadiponectinexpressioninmonocytesmacrophagesthroughtheampactivatedproteinkinasepathway |